A carregar...
Response to crizotinib in a lung adenocarcinoma patient harboring EML4-ALK translocation with adnexal metastasis: A Case Report
BACKGROUND: Lung cancer with ovarian metastasis or adnexal metastasis harboring anaplastic lymphoma kinase (ALK) gene translocation is rare. Crizotinib, a novel ALK tyrosine kinase inhibitor, has already shown an impressive single-agent activity in ALK positive lung cancer. METHODS: To summarize the...
Na minha lista:
| Publicado no: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Health
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5265830/ https://ncbi.nlm.nih.gov/pubmed/27472693 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000004221 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|